TipRanks
Fulgent Genetics Inc (FLGT)
NASDAQ:FLGT
US Market
Want to see FLGT full AI Analyst Report?

Fulgent Genetics (FLGT) Blogger Opinions & Sentiment

1,645 Followers

Blogger Sentiment

Bullish: 100.00%
Sector Average
Bullish
FLGT Blogger sentiment is based on 4 Blogger Opinions. The Blogger sentiment is more Bullish than other stocks in the Healthcare sector.

Blogger Article Distribution

ArticleDistribution
25% SeekingAlpha
25% Zacks
25% GuruFocus
25% Others
The distribution of articles among the main online Financial Blogging platforms.

Top Blogger Bearish Predictions

Not enough top blogger opinions at this time
Please return soon. This page is being updated.
Recent negative articles by top bloggers.

Top Blogger Bullish Predictions

PRPO vs. FLGT: Which Cancer Diagnostics Stock Has More Upside Now
Zacks
Fulgent Genetics: Strong Moves By Management Keep Me Bullish
SeekingAlpha
Fulgent Genetics (FLGT) Reports Strong Q4 Revenue Growth
GuruFocus
Recent positive articles by top bloggers.

Financial Blogger Predictions​​

Blogger Performance
Any
Any
Blogger Sentiment
Any
Any

FAQ

What do Seeking Alpha bloggers think of FLGT?
Seeking Alpha’s Eli Gooch has a Bullish Sentiment.
    What do Motley Fool contributors think of FLGT?
    Currently there's no blogger sentiment for FLGT.
    What Is FLGT’s Blogger Sentiment?
    FLGT’s Blogger Sentiment is Bullish.
      What was the most recent blogger prediction for FLGT?
      The most recent blogger prediction for FLGT was made by Debanjana Dey, who was Bullish on the stock.
        How can I follow the stock ratings of top Top Financial Bloggers?
        Head over to our Expert Center to see a list of the Top 100 Financial Bloggers and follow the financial bloggers of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Stocks with the Highest Top Blogger Ratings in the Healthcare sector
          HCAHCA Healthcare
          ABTAbbott Laboratories
          ARGXArgenx Se
          PRNAFAlterity Therapeutics
          VRTXVertex Pharmaceuticals